title: Targeting mechanisms at sites of complement activation for imaging and therapy.
abstract: The complement system plays a key role in many acute injury states as well as chronic autoimmune and inflammatory diseases. Localized complement activation and alternative pathway-mediated amplification on diverse target surfaces promote local recruitment of pro-inflammatory cells and elaboration of other mediators. Despite a general understanding of the architecture of the system, though, many of the mechanisms that underlie site-specific complement activation and amplification in vivo are incompletely understood. In addition, there is no capability yet to measure the level of local tissue site-specific complement activation in patients without performing biopsies to detect products using immunohistochemical techniques. Herein is reviewed emerging evidence obtained through clinical research studies of human rheumatoid arthritis along with translational studies of its disease models which demonstrate that several parallel mechanisms are involved in site-specific amplification of activation of the complement system in vivo. Among these processes are de-regulation of the alternative pathway, effector pathway-catalyzed amplification of proximal complement activation, recognition of injury-associated ligands by components of the lectin pathway, and engagement of pathogenic natural antibodies that recognize a limited set of injury-associated neoepitopes. Studies suggest that each of these inter-related processes can play key roles in amplification of complement-dependent injury on self-tissues in vivo. These findings, in addition to development of an imaging strategy described herein designed to quantitatively measure local complement C3 fixation, have relevance to therapeutic and diagnostic strategies targeting the complement system.
authors.affiliation: Division of Rheumatology, Department of Medicine, University of Colorado School of Medicine, PO Box 6511, Mail Stop B115, Aurora, CO 80045, United States. Electronic address: michael.holers@ucdenver.edu.
authors.forename: V Michael
authors.initials: VM
authors.lastname: Holers
mesh_terms: D000818:Animals; D000906:Antibodies / Q000378:metabolism; D000936:Antigen-Antibody Complex / Q000378:metabolism*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000628:therapy; D003167:Complement Activation; D003176:Complement C3 / Q000378:metabolism; D003952:Diagnostic Imaging; D004195:Disease Models, Animal; D006801:Humans; D056724:Immunity, Humoral; D058990:Molecular Targeted Therapy
chemical_list: D000906:Antibodies; D000936:Antigen-Antibody Complex; D003176:Complement C3
keywords: Alternative pathway; Arthritis; Complement therapeutics; Effector pathways; Lectin pathway; Molecular imaging; Pathogenesis